Profil
Helen Hovenga is currently the Chief People Officer & Head-Human Resources at Nuchev Ltd. She previously worked as the Executive Director-People & Culture at Peter MacCallum Cancer Institute from 2018 to 2020 and as the Global Chief People Officer at Telix Pharmaceuticals Ltd. from 2021 to 2022.
Ms. Hovenga holds an MBA from Charles Sturt University and an undergraduate degree from Swinburne University of Technology.
Aktive Positionen von Helen Hovenga
| Unternehmen | Position | Beginn |
|---|---|---|
| NUCHEV LIMITED | Personalreferent | 01.01.2023 |
Ehemalige bekannte Positionen von Helen Hovenga
| Unternehmen | Position | Ende |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Personalreferent | 01.09.2022 |
Peter MacCallum Cancer Institute
Peter MacCallum Cancer Institute General GovernmentGovernment Provides health care services | Personalreferent | 01.12.2020 |
Ausbildung von Helen Hovenga
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Charles Sturt University
Charles Sturt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swinburne University of Technology
Swinburne University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Peter MacCallum Cancer Institute
Peter MacCallum Cancer Institute General GovernmentGovernment Provides health care services | Government |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Nuchev Ltd.
Nuchev Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Develops, produces and sells milk based nutrition products | Consumer Non-Durables |
















